BC Drug and Poison Information Centre (DPIC) has recently joined Environmental Health Services (EHS) at the BC Centre for Disease Control (BCCDC). Together we provide comprehensive medical and public health expertise about cases of environmental exposures to toxic substances.
A family physician from a rural BC community contacted the DPIC regarding a 2-year-old girl with a blood lead level of 1.29 µmol/L (26.7 µg/dL).
The child was brought in by the mother who was concerned about delayed speech and poor social interaction. The medical assessment revealed developmental delay including fine motor skills. The child exhibited pica, the consistent consumption of non-nutritious material.
A consulting pediatrician ordered screening blood work and suggested the developmental delay was consistent with autism. DPIC toxicologists were consulted for the blood lead level, and recommended to not chelate at this point but to start with nutritional and exposure assessments.
All family members sharing a residence were tested for lead exposure. There were no other children among them. An environmental investigation conducted by an EHS physician and regional health authority staff found multiple potential exposure sources including deteriorating interior and exterior paint. Samples were sent for testing.
The investigation was ongoing at the time of writing and health protection measures will be considered, if appropriate, once the environmental investigation is completed.
Lead is a well-known environmental contaminant with significant health effects. Chronic lead poisoning in children is an insidious process causing neurological effects such as decreased IQ, attention deficit and impaired motor coordination. Evidence suggests that fetal exposure also causes neurologic damage.
The major sources of lead exposure for Canadian children are dust and paint chips indoors. Exposure occurs when dust is tracked indoors from outdoor sources, and dust and chips are formed from leaded paint in older houses that is degrading or exposed during renovation. Infants and young children are particularly susceptible due to their frequent hand-to-mouth activity, as are toddlers and older children with pica.
Other exposure sources include imported products such as toys, costume jewelry, cookware, cosmetics, and alternative medications. Two Health Canada recalls of children’s jewelry in 2010 serve as reminders that avoidable sources of lead exposure for children are still an issue.
There is no known safe level of lead exposure. Although the Health Canada guidance value* for lead in blood is 0.48 µmol/L (10 µg/dL), evidence demonstrates that permanent cognitive deficits occur in children with lower blood lead levels (BLLs) in the range of 0.10 to 0.48 µmol/L.[3,4]
The magnitude and nature of these effects vary based on individual and social-environmental factors (e.g., early childhood development). Cognitive deficits associated with lead exposure can ultimately manifest as poor school performance, fewer years of employment, and reduced earnings.
Prevention of lead exposure in children can result in profound increases in societal productivity. For example, one US estimate found that the decrease in BLLs for preschoolers from the late 1970s to the late 1990s (0.72 µmol/L, 15 µg/dL) resulted in average IQ increase of 2.2. to 4.7 points, which corresponded with a $100 billion to $319 billion economic benefit for each year’s cohort of 3.8 million 2-year-olds (in US dollars for the year 2000).
Our case study illustrates the complementary roles of the Drug and Poison Information Centre and the Environmental Health Services. DPIC provides a toll-free province-wide telephone information service staffed by specially trained pharmacists, nurses, and clinical toxicologists.
DPIC provides expertise on clinical management of intoxications including use of antidotes and appropriate medical follow-up.
Public health physicians at EHS work with regional health authorities to conduct investigations into cases of toxic exposures where the public may be at risk—for example those involving exposure in public venues (e.g., carbon monoxide in a hockey arena) and those involving exposure sources that may be widely distributed (e.g., consumer products). Together we provide a comprehensive service from clinical care to health protection.
Physicians interested in clinical support and/or public health follow-up of cases may reach the 24/7 BC Drug and Poison Information Centre at 604 682-5050 or 1 800 567-8911. For assistance with public health follow-up including exposure assessment and health protection, physicians may contact their medical health officer or EHS directly at 604 707-2440.
—Catherine Elliott, MD, CCFP, FRCPC
Environmental Health Services
—Debra Kent, BA, PharmD, DABAT
BC Drug and Poison Information Centre
* Health Canada defines a guidance value as the level above which action may be considered to reduce exposure.
This article is the opinion of the BCCDC and has not been peer reviewed by the BCMJ Editorial Board.
1. Agency for Toxic Substances and Disease Registry (ATSDR). Lead toxicity. What are the physiologic effects of lead exposure? Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Case Studies in Environmental Medicine (CSEM); 2007 Aug. Accessed DD MONTH 2011. www.atsdr.cdc.gov/csem/lead/pbphysiologic_effects2.html.
2. U.S. Centers for Disease Control and Prevention. Guidelines for the identification and management of lead exposure in pregnant and lactating women. In: Ettinger AS, Wengrovitz AG, Portier C, Brown MJ (eds). Atlanta, GA: US Department of Health and Human Services; 2010.
3. Bellinger DC. Very low lead exposures and children’s neurodevelopment. Curr Opin Pediatr 2008;20:172.
4. Binns HJ, Campbell C, Brown MJ. Interpreting and managing blood lead levels of less than 10 microg/dL in children and reducing childhood exposure to lead: Recommendations of the Centers for Disease Control and Prevention Advisory Committee on Childhood Lead Poisoning Prevention. Pediatrics 2007;120:e1285-e1298.
5. Grosse SD, Matte TD, Schwartz J, et al. Economic gains resulting from the reduction in children’s exposure to lead in the United States. Environ Health Perspect 2002;110:563-569.
Above is the information needed to cite this article in your paper or presentation. The International Committee
of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally
accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
About the ICMJE and citation styles
The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.
An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.
BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:
- Only the first three authors are listed, followed by "et al."
- There is no period after the journal name.
- Page numbers are not abbreviated.
For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org